128 related articles for article (PubMed ID: 21193745)
1. Soluble glycoprotein VI is raised in the plasma of patients with acute ischemic stroke.
Al-Tamimi M; Gardiner EE; Thom JY; Shen Y; Cooper MN; Hankey GJ; Berndt MC; Baker RI; Andrews RK
Stroke; 2011 Feb; 42(2):498-500. PubMed ID: 21193745
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of soluble glycoprotein VI (sGPVI) are associated with ischemic stroke.
Wurster T; Poetz O; Stellos K; Kremmer E; Melms A; Schuster A; Nagel E; Joos T; Gawaz M; Bigalke B
Platelets; 2013; 24(7):560-5. PubMed ID: 23215725
[TBL] [Abstract][Full Text] [Related]
3. Decreased levels of platelet-derived soluble glycoprotein VI detected prior to the first diagnosis of coronary artery disease in HIV-positive individuals.
Trevillyan JM; Gardiner EE; Andrews RK; Maisa A; Hearps AC; Al-Tamimi M; Crowe SM; Hoy JF
Platelets; 2017 May; 28(3):301-304. PubMed ID: 27848272
[TBL] [Abstract][Full Text] [Related]
4. Properties of soluble glycoprotein VI, a potential platelet activation biomarker.
Naitoh K; Hosaka Y; Honda M; Ogawa K; Shirakawa K; Furusako S
Platelets; 2015; 26(8):745-50. PubMed ID: 25549161
[TBL] [Abstract][Full Text] [Related]
5. Soluble GPVI is elevated in injured patients: shedding is mediated by fibrin activation of GPVI.
Montague SJ; Delierneux C; Lecut C; Layios N; Dinsdale RJ; Lee CS; Poulter NS; Andrews RK; Hampson P; Wearn CM; Maes N; Bishop J; Bamford A; Gardiner C; Lee WM; Iqbal T; Moiemen N; Watson SP; Oury C; Harrison P; Gardiner EE
Blood Adv; 2018 Feb; 2(3):240-251. PubMed ID: 29437639
[TBL] [Abstract][Full Text] [Related]
6. Soluble glycoprotein VI, a specific marker of platelet activation is increased in the plasma of subjects with seropositive rheumatoid arthritis.
Stack JR; Madigan A; Helbert L; Dunne E; Gardiner EE; Andrews RK; Finan R; Smyth E; Kenny D; McCarthy GM
PLoS One; 2017; 12(11):e0188027. PubMed ID: 29141000
[TBL] [Abstract][Full Text] [Related]
7. Increased platelet reactivity as measured by plasma glycoprotein VI in gout.
Conway R; Murphy CL; Madigan A; Kavanagh P; Geraghty L; Redmond N; Helbert L; Carey JJ; Dunne E; Kenny D; McCarthy GM
Platelets; 2018 Dec; 29(8):821-826. PubMed ID: 29090618
[TBL] [Abstract][Full Text] [Related]
8. Elevated plasma levels of soluble platelet glycoprotein VI (GPVI) in patients with thrombotic microangiopathy.
Yamashita Y; Naitoh K; Wada H; Ikejiri M; Mastumoto T; Ohishi K; Hosaka Y; Nishikawa M; Katayama N
Thromb Res; 2014 Mar; 133(3):440-4. PubMed ID: 24325877
[TBL] [Abstract][Full Text] [Related]
9. Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes.
Cherian P; Hankey GJ; Eikelboom JW; Thom J; Baker RI; McQuillan A; Staton J; Yi Q
Stroke; 2003 Sep; 34(9):2132-7. PubMed ID: 12907813
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of soluble EMMPRIN (CD147) correlate with levels of soluble glycoprotein VI in human plasma.
Pennings GJ; Yong AS; Wong C; Al-Tamimi M; Gardiner EE; Andrews RK; Kritharides L
Platelets; 2014; 25(8):639-42. PubMed ID: 24245520
[TBL] [Abstract][Full Text] [Related]
11. Increased platelet CD63 and P-selectin expression persist in atherosclerotic ischemic stroke.
Cha JK; Jo WS; Shin HC; Bae HR; Ho JM; Kim JW
Platelets; 2004 Feb; 15(1):3-7. PubMed ID: 14985170
[TBL] [Abstract][Full Text] [Related]
12. Platelet and monocyte activation in acute ischemic stroke--is there a correlation with stroke etiology?
Oberheiden T; Nguyen XD; Fatar M; Elmas E; Blahak C; Morper N; Dempfle CE; Hennerici M; Borggrefe M; Kälsch T
Clin Appl Thromb Hemost; 2012; 18(1):87-91. PubMed ID: 21733938
[TBL] [Abstract][Full Text] [Related]
13. Shedding of soluble glycoprotein VI is neither affected by animal-derived antibeta-2-glycoprotein 1 antibodies nor IgG fractions from patients with systemic lupus erythematosus.
Ho YC; Ahuja KDK; Andrews RK; Adams MJ
Blood Coagul Fibrinolysis; 2020 Jun; 31(4):258-263. PubMed ID: 32205472
[TBL] [Abstract][Full Text] [Related]
14. Association of platelet-derived soluble glycoprotein VI in plasma with Alzheimer's disease.
Laske C; Leyhe T; Stransky E; Eschweiler GW; Bueltmann A; Langer H; Stellos K; Gawaz M
J Psychiatr Res; 2008 Jul; 42(9):746-51. PubMed ID: 17854831
[TBL] [Abstract][Full Text] [Related]
15. Sandwich immunoassay for soluble glycoprotein VI in patients with symptomatic coronary artery disease.
Bigalke B; Pötz O; Kremmer E; Geisler T; Seizer P; Puntmann VO; Phinikaridou A; Chiribiri A; Nagel E; Botnar RM; Joos T; Gawaz M
Clin Chem; 2011 Jun; 57(6):898-904. PubMed ID: 21474641
[TBL] [Abstract][Full Text] [Related]
16. Soluble glycoprotein VI is a predictor of major bleeding in patients with suspected heparin-induced thrombocytopenia.
Pishko AM; Andrews RK; Gardiner EE; Lefler DS; Cuker A
Blood Adv; 2020 Sep; 4(18):4327-4332. PubMed ID: 32915974
[TBL] [Abstract][Full Text] [Related]
17. Elevated soluble platelet glycoprotein VI is a useful marker for DVT in postoperative patients treated with edoxaban.
Aota T; Naitoh K; Wada H; Yamashita Y; Miyamoto N; Hasegawa M; Wakabayashi H; Yoshida K; Asanuma K; Matsumoto T; Ohishi K; Shimokariya Y; Yamada N; Nishikawa M; Katayama N; Uchida A; Sudo A
Int J Hematol; 2014 Nov; 100(5):450-6. PubMed ID: 25253166
[TBL] [Abstract][Full Text] [Related]
18. [C-reactive protein and carotid intima-media thickness in atherothrombotic ischemic stroke].
Arévalo Lorido JC; Carretero Gómez J
Med Clin (Barc); 2009 Oct; 133(13):496-500. PubMed ID: 19748637
[TBL] [Abstract][Full Text] [Related]
19. Elevated Soluble Platelet Glycoprotein VI Levels in Patients After Living Donor Liver Transplantation.
Takahashi N; Usui M; Naitoh K; Wada H; Mastsui T; Kobayashi T; Matsumoto T; Uemoto S; Isaji S
Clin Appl Thromb Hemost; 2017 Apr; 23(3):274-281. PubMed ID: 26346441
[TBL] [Abstract][Full Text] [Related]
20. Lp(a) lipoprotein and plasminogen activity in patients with different etiology of ischemic stroke.
Petersen NH; Schmied AB; Zeller JA; Plendl H; Deuschl G; Zunker P
Cerebrovasc Dis; 2007; 23(2-3):188-93. PubMed ID: 17143002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
